Michael Rapp, Director at Immunome Inc. (IMNM), bought 51,924 shares at $19.96 ($1.0M) on 2021-09-13, disclosed to the SEC on 2021-09-14.
Open-market purchase of $1.0M IMNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.96 | 25,962 | $518K | 50.0% |
| 2 | $19.96 | 25,962 | $518K | 50.0% |
| Total | $19.96 avg | 51,924 | $1.0M | 100% |
| Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-31 | $123K | — | Filing → |
| ZYNE | BUY | 2018-05-02 | $157K | — | Filing → |